Publications
Specialty
Search
EP Lab Digest
07/02/2024
The use of 4D intracardiac echocardiography catheters for left atrial appendage occlusion holds tremendous promise for improved efficiency and decreased overall resource utilization.
EP Lab Digest
07/02/2024
Sarah Vanderhoff, MSN, RN, and Andrew Feltgen, RT(R), describe the development, structure, and outcomes of Scripps’ Interventional Cardiology Rad Tech Transition Program.
EP Lab Digest, CardioVascular
Atrial Fibrillation: Recent Clinical Studies, Latest Technologies, and Expanded Use in Heart Failure
07/02/2024
In this episode, Randall Lee, MD, talks with Kenneth Ellenbogen, MD, FHRS, and Hugh Calkins, MD, about the role of atrial fibrillation ablation in patients with heart failure, including recent clinical trials, new technologies, and the role of hybrid therapies.
Oncology
07/02/2024
Peter Galle, MD, PhD, discussed results from the CheckMate 9DW trial which identified nivolumab plus ipilimumab as a potential new first-line option for patients with previously untreated, unresectable hepatocellular carcinoma.
Wounds, Wound Care
07/02/2024
Objective: To assess previously published reports of the clinical effect of plasma rich in growth factors (PRGF) on chronic skin wounds.
Advances in Inflammatory Bowel Disease Network
07/02/2024
Dr Rubin recaps his address at Digestive Disease Week on positioning advanced therapies in IBD, emphasizing the importance of assessing disease activity, prognosis for complications, and using a treat to target approach to achieve and maintain remission.
Oncology
07/01/2024
Findings from the real-world CASSIOPEA study show the considerable disease burden of neurofibromatosis type 1 with plexiform neurofibromas (NF1-PN) highlighting the importance of effective treatments for this patient population.
Oncology
07/01/2024
Findings from a phase 2 study show vinblastine/methotrexate did not demonstrate activity for neurofibromatosis type 1 with plexiform neurofibromas (NF1-PN) in pediatric and young-adult patients, despite being well-tolerated.
Neurology
07/01/2024
Understanding prodrome symptoms may
result in more effective migraine
management. Watch our short video with
AbbVie paid consultant, Dr Stephanie
Nahas, to learn more about how to avoid
headache progression.
© 2024 AbbVie. All rights reserved.
ABBV-US-01555-MC, v1.0
Approved 04/2024
Psych Congress Network
07/01/2024
Your feedback helps shape our future content on bipolar I disorder and MDD. Please take a minute to complete this poll question.
ABBV-US-01688-MC, V1.0 | Approved 06/2024 | AbbVie Medical Affairs
First Report Managed Care
07/01/2024
In this interview, Katie Devlin, VP of Interoperability at Cotiviti, discusses the impact of major shifts like TEFCA and the CMS Interoperability Rule on health plans, emphasizing the importance of joining a QHIN to increase data availability.
Oncology
07/01/2024
Study findings show neurofibromatosis type 1 with plexiform neurofibromas (NF1-PN) worsens adult patient and caregiver health-related quality of life vs that of the general population.
Integrated Healthcare Executive
07/01/2024
Launching another cyclical, cost-cutting campaign is not enough to resolve the gap between revenue and expense growth rates. In this commentary, Mike Eaton, Market President, Navvis, details the strategies health care leaders should implement to help resolve this disparity.
Oncology
07/01/2024
Andrea Cercek, MD, discussed results from a phase 2 study which demonstrated durable recurrence-free with neoadjuvant dostarlimab among patients with locally advanced mismatch repair deficient rectal cancer.
Psych Congress Network, HMP Global Learning Network, Psychiatry & Behavioral Health
07/01/2024
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Cath Lab Digest
07/01/2024
A 66-year-old male Jehovah’s Witness arrived at the emergency room having experienced typical persistent angina.
Cath Lab Digest, Journal of Invasive Cardiology
07/01/2024
Reflow Medical, Inc. announces the first patient enrollments in “A pilot study of the Drug-Eluting Coronary Spur™ StEnt as a Primary trEatment for in-stent Restenosis (ISR) of the CORONARY arteries” (DEEPER CORONARY, NCT06117150).
Oncology
07/01/2024
The FDA has approved the new drug application for SH-105, a liquid formulation of thiotepa, for the treatment of patients with breast and ovarian cancer.
Wound Management & Prevention
07/01/2024